abstract |
The present invention relates to a humanized antibody having a high binding affinity for human IL-21 and neutralizing it, a condition in which the antagonism or neutralization of the effect of IL-21 is ensured using the antibody, Methods of treating immune system, compositions and methods for recombinantly producing such antibodies, and pharmaceutical compositions comprising such antibodies. |